GOVX GeoVax Labs, Inc.

Nasdaq geovax.com


$ 0.43 $ -0.03 (-5.8 %)    

Thursday, 13-Nov-2025 17:25:26 EST
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 0.469
$ 0.50
$ 0.42 x 65
$ 0.52 x 300
-- - --
$ 0.43 - $ 3.15
976,392
na
13.93M
$ 3.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 07-28-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 04-27-2022 03-31-2022 10-Q
16 03-09-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-23-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 03-24-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-13-2019 03-31-2019 10-Q
28 03-26-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-03-2018 03-31-2018 10-Q
32 03-23-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 03-24-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 03-16-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 geovax-labs-q3-eps-031-misses-025-estimate

Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25)...

 d-boral-capital-maintains-buy-on-geovax-labs-maintains-9-price-target

D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ: GOVX) with a Buy and maintains $9 price target.

 d-boral-capital-maintains-buy-on-geovax-labs-maintains-9-price-target

D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $9 price target.

 d-boral-capital-maintains-buy-on-geovax-labs-maintains-9-price-target

D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $9 price target.

 geovax-labs-q2-eps-035-beats-036-estimate-sales-852282k-beat-366667k-estimate

Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.36) b...

 earnings-preview-for-geovax-labs
Earnings Preview For Geovax Labs
07/25/2025 19:02:12

 d-boral-capital-maintains-buy-on-geovax-labs-maintains-9-price-target

D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $9 price target.

Core News & Articles

https://www.fox2detroit.com/news/1-person-dies-plague-northern-arizona?taid=6871388e1d7907000160979d&utm_campaign=trueanthe...

 reported-june-16-2025-geovax-labs-files-to-sell-615m-common-units-each-common-unit-consists-of-1-share-of-common-stock-and-2-common-warrants-to-purchase-1-share-of-common-stock

- SEC Filing

 geovaxs-geo-cm04s1-vaccine-shows-t-cell-responses-vs-mrna-vaccine-in-phase-2-trial-for-cll-patients-meeting-key-immunogenicity-endpoints-and-driving-continued-enrollment-at-2025-eha-congress-presentation

https://geovax.com/investors/press-releases/geovax-highlights-positive-immune-response-results-from-geo-cm04s1-in-cll-patients-...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION